FIELD: medicine.
SUBSTANCE: invention relates to cosmetic industry, namely to cosmetic preparation, which contains from 3×10-4 to 1×10-3 wt %, of, at least, one of particular steroids of 16-androstene series, in particular, 4,16-androstadien-3-one and particular steroids of estrene series, as well as from 0.1 to 30 wt % of, at least one film-generating and/or fixing polymer.
EFFECT: claimed cosmetic preparation ensures prevention of unpleasant smell of used steroids in addition to fixation of keratin fibres due to their fixed release due to application of film-generating polymers.
13 cl, 2 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| 0 |
|
SU514573A3 | |
| TRANSDERMAL STEROID COMPOSITIONS | 2005 |
|
RU2371183C2 |
| 17 β -OXYESTRATRIENES | 2002 |
|
RU2339643C2 |
| COMPOSITION FOR HAIR STYLING CONTAINING POLYMER WITH SPECIAL CHARACTERISTICS AND FILM-FORMING ION POLYMER | 1999 |
|
RU2183449C2 |
| 0 |
|
SU301921A1 | |
| 17α-ALKYL-17β-HYDROXYESTRATRIENES, THEIR USING AND PHARMACEUTICAL PREPARATION | 2002 |
|
RU2285009C2 |
| COSMETIC PREPARATION | 2007 |
|
RU2463036C2 |
| DEVICE IN FORM OF FLASK-PUMP CONTAINING POLYCONDENSATE INCLUDING AT LEAST ONE POLYURETHANE AND/OR POLYCARBAMIDE FRAGMENT | 1999 |
|
RU2203101C2 |
| METHOD OF TREATMENT OF PATIENTS WITH PROSTATE BENIGNITY HYPERPLASIA, PHARMACEUTICAL PREPARATION CONTAINING INHIBITOR OF 5-ALPHA-REDUCTASE | 1992 |
|
RU2125879C1 |
| BRIDGE-CONTAINING ESTRATRIENES | 1990 |
|
RU2087479C1 |
